Thomas Dayspring ✓

@Drlipid · Richmond, VA · joined 15 Jul 2009

MD, FACP, MNLA - Clinical Lipidologist: Tweets/Re-Tweets do not represent endorsements/medical advice

146 894Followers

612Following

22 051Posts total

35.4KViews on collected posts

Derniers posts

Thomas Dayspring ✓@Drlipid12 Sep

NATIONAL CHOLESTEROL EDUCATION MONTH - Hepatic produced VLDLs and enteric produced Chylomicrons undergo lipoprotein lipase mediated lipolysis (graphic 2 shows the complexities) in adipocyte and myocyte beds in which TGs release their fatty acids for use but as the particles https

3.5K views · 25 likes · 5 reposts · 0 replies Open on X →

Thomas Dayspring ✓@Drlipid12 Sep

NATIONAL CHOLESTEROL EDUCATION MONTH - Hepatic produced LDLs carry cholesteryl ester (CE) for stoichiometric (structural) reasons to keep the particle spherical. During their long plasma residence time of a few days, LDLs do not deliver cholesterol or the small amount of TG they

3.7K views · 30 likes · 2 reposts · 0 replies Open on X →

Thomas Dayspring ✓@Drlipid12 Sep

@Drlipid Tom what is the main role of the LDLs that are directly made by the liver? Is it still to deliver trigs to cells? 78 views · 0 likes · 0 reposts · 1 replies Open on X →

Thomas Dayspring ✓@Drlipid12 Sep

@Drlipid The dose makes the poison as with all things. Where do you keep your apo B number 80 views · 0 likes · 0 reposts · 0 replies Open on X →

Thomas Dayspring ✓@Drlipid11 Sep

@Drlipid @lipo 103 views · 0 likes · 0 reposts · 0 replies Open on X →

Thomas Dayspring ✓@Drlipid11 Sep

I see many posts uniformly calling apoB-containing lipoproteins as "Atherogenic." That is a misstatement as many apoB particles perform critical physiologic functions and thus are not atherogenic. ApoB particles can be atherogenic if they enter and are retained by the artery http

9.8K views · 101 likes · 19 reposts · 11 replies Open on X →

Thomas Dayspring ✓@Drlipid9 Sep

Important study: MHT for the right woman is an excellent therapy - but it is not a CV or lipid-modulating therapy per se. But when used as indicated for vasomotor symptoms in peri- and early menopause it seems some CV benefit will follow. https://t.co/Ok7HnyCZWl @nationallipid

4.3K views · 16 likes · 1 reposts · 0 replies Open on X →

Thomas Dayspring ✓@Drlipid8 Sep

@Drlipid Isn’t the lpa particle much more atherogenic that the ldl particle. I recall 8x or so per Sam Tsimikas. 107 views · 0 likes · 0 reposts · 1 replies Open on X →

Thomas Dayspring ✓@Drlipid8 Sep

SEPTEMBER = National #Cholesterol Education Month -So, here is some mind-boggling mathematical and cholesterol fun. Let's compare LDL-C mass (mg/dL or mmol/L) vs LDL-P (nmol/L) and relate it to the # of actual cholesterol molecules being trafficked in 1 liter of plasma in someone

4.5K views · 25 likes · 2 reposts · 1 replies Open on X →

Thomas Dayspring ✓@Drlipid7 Sep

@Drlipid @theproof @dan_soffer @nationallipid @foundationofnla @society_eas @ASPCardio @escardio @atherosociety @TheEndoSociety @FamilyHeartFdn @fhpatienteurope Looking forward to listening After all , I have to protect my 3 grafts for as long as possible.👍🤗🙏 128 views · 0 likes · 0 reposts · 0 replies Open on X →

Thomas Dayspring ✓@Drlipid7 Sep

@Drlipid @theproof @dan_soffer @nationallipid @foundationofnla @society_eas @ASPCardio @escardio @atherosociety @TheEndoSociety @FamilyHeartFdn @fhpatienteurope There is no case that can be remotely acceptably made. The sum total of evidence establishing LDL as the cause of ASCVD 291 views · 9 likes · 1 reposts · 1 replies Open on X →

Thomas Dayspring ✓@Drlipid7 Sep

@Drlipid @theproof @dan_soffer @nationallipid @foundationofnla @society_eas @ASPCardio @escardio @atherosociety @TheEndoSociety @FamilyHeartFdn @fhpatienteurope This framing matters. Waiting for plaque to show up on imaging is a different question than lifetime exposure. Looking 122 views · 0 likes · 0 reposts · 0 replies Open on X →

Thomas Dayspring ✓@Drlipid7 Sep

Here is the next @theproof Tag-Team podcast with @dan_soffer and me, discussing how to best prevent atherosclerosis. ENJOY! https://t.co/zeYAALOPDw @nationallipid @foundationofnla @society_eas @ASPCardio @escardio @atherosociety @TheEndoSociety @FamilyHeartFdn @fhpatienteurope

8.6K views · 46 likes · 8 reposts · 3 replies Open on X →

Face aux comptes de taille comparable

13 posts des 90 derniers jours, à côté de la tranche de 100K–1M abonnés. en dessous de ses pairs à la fois en portée et en engagement.

Vues médianes291ce compte5 954médiane pour 100K–1M

Portée, %0.20%ce compte1.59%médiane pour 100K–1M

Engagement, %0.66%ce compte1.05%médiane pour 100K–1M

Indicateur	Ce compte	Médiane pour 100K–1M	Rapport
Vues médianes par post	291	5 954	0.05×
Portée (vues ÷ abonnés)	0.20%	1.59%	0.12×
Taux d'engagement	0.66%	1.05%	0.63×

Autres comptes de cette tranche → Comparer avec un autre compte → Comment ces repères sont établis →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

8.6K7 Sep

122

291

128

4.5K8 Sep

107

4.3K9 Sep

9.8K11 Sep

103

8012 Sep

3.7K

3.5K

Last 13 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.66%7 Sep

0.00%

3.78%

0.00%

0.62%8 Sep

0.93%

0.40%9 Sep

1.34%11 Sep

0.00%

0.00%12 Sep

1.28%

0.86%

0.85%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.05%.

What the audience does

Likes57.5%252 in total

Reposts8.7%38 in total

Replies4.1%18 in total

Bookmarks29.7%130 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Derniers posts

Face aux comptes de taille comparable

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Comptes similaires